Arkolith/Insider Trading/BSX/Form 4

Fitzgerald Joseph Michael

EVP & Group Pres, CardiologyBOSTON SCIENTIFIC CORP (BSX) · full profile →Form 4 · filed Feb 18, 2026
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
11
8 non-derivative · 3 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Feb 16, 2026Tax withholding(F)2K$74.73$135K214K
Feb 16, 2026Option exercise(M)4K—$0216K
Feb 14, 2026Tax withholding(F)2K$74.73$149K212K
Feb 14, 2026Option exercise(M)4K—$0214K
Feb 13, 2026Option exercise(M)3K—$0242K
Feb 13, 2026Tax withholding(F)33K$74.73$2.5M209K
Feb 13, 2026Grant(A)35K—$0240K
Feb 13, 2026Grant(A)35K—$0205K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Feb 16, 2026Option exercise(M)4K—$00
Feb 14, 2026Option exercise(M)4K—$04K
Feb 13, 2026Option exercise(M)3K—$08K

Transaction Codes

F
Shares withheld for taxes
M
Option exercise / conversion
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001225208-26-002134) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML